BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22547745)

  • 1. Use of implantable cardioverter defibrillators in patients with left ventricular assist devices.
    Pettit SJ; Petrie MC; Connelly DT; Japp AG; Payne JR; Haj-Yahia S; Gardner RS
    Eur J Heart Fail; 2012 Jul; 14(7):696-702. PubMed ID: 22547745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Randomized Evaluation of Implantable Cardioverter-Defibrillator Programming in Patients With a Left Ventricular Assist Device.
    Richardson TD; Hale L; Arteaga C; Xu M; Keebler M; Schlendorf K; Danter M; Shah A; Lindenfeld J; Ellis CR
    J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29475875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular arrhythmias and implantable cardioverter-defibrillator therapy in patients with continuous-flow left ventricular assist devices: need for primary prevention?
    Garan AR; Yuzefpolskaya M; Colombo PC; Morrow JP; Te-Frey R; Dano D; Takayama H; Naka Y; Garan H; Jorde UP; Uriel N
    J Am Coll Cardiol; 2013 Jun; 61(25):2542-50. PubMed ID: 23643502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator shocks in patients with a left ventricular assist device.
    Ambardekar AV; Allen LA; Lindenfeld J; Lowery CM; Cannon AP; Cleveland JC; Brieke A; Sauer WH
    J Heart Lung Transplant; 2010 Jul; 29(7):771-6. PubMed ID: 20347337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable defibrillator therapy for ventricular tachyarrhythmia in left ventricular assist device patients.
    Oswald H; Schultz-Wildelau C; Gardiwal A; Lüsebrink U; König T; Meyer A; Duncker D; Pichlmaier MA; Klein G; Strüber M
    Eur J Heart Fail; 2010 Jun; 12(6):593-9. PubMed ID: 20406799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of ventricular arrhythmias in patients on long-term support with a continuous-flow assist device (HeartMate II).
    Andersen M; Videbaek R; Boesgaard S; Sander K; Hansen PB; Gustafsson F
    J Heart Lung Transplant; 2009 Jul; 28(7):733-5. PubMed ID: 19560703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
    Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
    Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular mechanical assist devices and cardiac device interactions: an observational case series.
    Foo D; Walker BD; Kuchar DL; Thorburn CW; Tay A; Hayward CS; Macdonald P; Keogh A; Kotlyar E; Spratt P; Jansz P
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):879-87. PubMed ID: 19572863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of mortality for ventricular arrhythmia in ambulatory LVAD patients.
    Brenyo A; Rao M; Koneru S; Hallinan W; Shah S; Massey HT; Chen L; Polonsky B; McNitt S; Huang DT; Goldenberg I; Aktas M
    J Cardiovasc Electrophysiol; 2012 May; 23(5):515-20. PubMed ID: 22081967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ICD lead parameters, performance, and adverse events following continuous-flow LVAD implantation.
    Thomas IC; Cork DP; Levy A; Nayak H; Beshai JF; Burke MC; Moss JD
    Pacing Clin Electrophysiol; 2014 Apr; 37(4):464-72. PubMed ID: 24237034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse interaction between a left ventricular assist device and an implantable cardioverter defibrillator.
    Matthews JC; Betley D; Morady F; Pelosi F
    J Cardiovasc Electrophysiol; 2007 Sep; 18(10):1107-8. PubMed ID: 17403078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure and the risk of shocks in patients with implantable cardioverter defibrillators: results from the Triggers Of Ventricular Arrhythmias (TOVA) study.
    Whang W; Mittleman MA; Rich DQ; Wang PJ; Ruskin JN; Tofler GH; Muller JE; Albert CM;
    Circulation; 2004 Mar; 109(11):1386-91. PubMed ID: 14993132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electromagnetic interference from left ventricular assist devices in patients with subcutaneous implantable cardioverter-defibrillators.
    Ishida Y; Payne JE; Field ME; Gold MR
    J Cardiovasc Electrophysiol; 2020 May; 31(5):1195-1201. PubMed ID: 32128931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.
    Obeyesekere MN; Chan W; Stub D; Prabhu S; Teo EP; Toogood G; Mariani J; Broughton A; Kistler PM
    Pacing Clin Electrophysiol; 2010 Jun; 33(6):696-704. PubMed ID: 20059719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers].
    Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L
    Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable cardioverter-defibrillator shocks: epidemiology, outcomes, and therapeutic approaches.
    Borne RT; Varosy PD; Masoudi FA
    JAMA Intern Med; 2013 May; 173(10):859-65. PubMed ID: 23546173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Initial clinical results with a novel implantable cardioverter-defibrillator: a prospective evaluation in 3 Swiss university hospitals].
    Osswald S; Candinas R; Fuhrer J
    Schweiz Med Wochenschr; 1995 Dec; 125(50):2423-32. PubMed ID: 8553030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electromagnetic interference of automatic implantable cardioverter defibrillator and HeartWare left ventricular assist device.
    Labedi MR; Alharethi R; Kfoury AG; Budge D; Bruce R; Rasmusson B; Bunch TJ
    ASAIO J; 2013; 59(2):136-9. PubMed ID: 23438775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular arrhythmias in patients with implanted cardioverter defibrillators.
    John RM; Stevenson WG
    Trends Cardiovasc Med; 2012 Oct; 22(7):169-73. PubMed ID: 22902094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.